These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21907090)

  • 1. Genetics of tardive dyskinesia.
    Lee HJ; Kang SG
    Int Rev Neurobiol; 2011; 98():231-64. PubMed ID: 21907090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and tardive dyskinesia: pharmacogenetic evidence.
    Cho CH; Lee HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():207-13. PubMed ID: 23123399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
    Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.
    Thelma B; Srivastava V; Tiwari AK
    Pharmacogenomics; 2008 Sep; 9(9):1285-306. PubMed ID: 18781856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The genetics of antipsychotic-related movement disorders].
    Bakker PR; van Os J; van Harten PN
    Tijdschr Psychiatr; 2015; 57(2):114-9. PubMed ID: 25669949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genome-wide association analyses for neuroleptic-induced tardive dyskinesia].
    Arinami T; Inada T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):155-62. PubMed ID: 21941849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.
    Greenbaum L; Alkelai A; Zozulinsky P; Kohn Y; Lerer B
    Pharmacogenomics J; 2012 Dec; 12(6):513-20. PubMed ID: 21808285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
    Zai CC; Tiwari AK; Basile V; De Luca V; Müller DJ; King N; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Pharmacogenomics J; 2009 Jun; 9(3):168-74. PubMed ID: 19238168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of tardive dyskinesia: an updated review of the literature.
    Lanning RK; Zai CC; Müller DJ
    Pharmacogenomics; 2016 Aug; 17(12):1339-51. PubMed ID: 27469238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors for (tardive) dyskinesia.
    Tenback DE; van Harten PN
    Int Rev Neurobiol; 2011; 98():211-30. PubMed ID: 21907089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness.
    de Leon J; Susce MT; Pan RM; Koch WH; Wedlund PJ
    J Clin Psychopharmacol; 2005 Oct; 25(5):448-56. PubMed ID: 16160620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia.
    Kang SG; Lee HJ; Choi JE; An H; Rhee M; Kim L
    Hum Psychopharmacol; 2009 Jan; 24(1):55-60. PubMed ID: 19051221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.